Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone-Ondansetron vs Dexamethasone-Haloperidol for PONV
NCT06428084Phase 2Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of haloperidol in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Universitas Padjadjaran. Primary endpoint: Nausea and Vomiting Score at 24 hours. Started Nov 2023; status: completed.
02
Drugs
haloperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06428084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06428084.